1 Study Coverage 1.1 Haemophilus Influenzae Type B Vaccine Product Introduction 1.2 Market by Type 1.2.1 Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Type 1.4.2 Liquid Monovalent HIB 1.4.3 Liquid Combination HIB 1.2.4 Lyophilized Monovalent HIB 1.2.5 Lyophilized Combination HIB 1.3 Market by Application 1.3.1 Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Application 1.3.2 Hospital 1.3.3 Research Institutions 1.3.4 Pharmaceutical and Biotechnology Companies 1.3.5 Academic Institutions 1.3.6 Other 1.4 Study Objectives 1.5 Years Considered 2 Executive Summary 2.1 Global Haemophilus Influenzae Type B Vaccine Sales Estimates and Forecasts 2016-2027 2.2 Global Haemophilus Influenzae Type B Vaccine Revenue Estimates and Forecasts 2016-2027 2.3 Global Haemophilus Influenzae Type B Vaccine Revenue by Region: 2016 VS 2021 VS 2027 2.4 Global Top Haemophilus Influenzae Type B Vaccine Regions by Sales 2.4.1 Global Top Haemophilus Influenzae Type B Vaccine Regions by Sales (2016-2021) 2.4.2 Global Top Haemophilus Influenzae Type B Vaccine Regions by Sales (2022-2027) 2.5 Global Top Haemophilus Influenzae Type B Vaccine Regions by Revenue 2.5.1 Global Top Haemophilus Influenzae Type B Vaccine Regions by Revenue (2016-2021) 2.5.2 Global Top Haemophilus Influenzae Type B Vaccine Regions by Revenue (2022-2027) 2.6 North America 2.7 Europe 2.8 Asia-Pacific 2.9 Latin America 2.10 Middle East & Africa 3 Competition by Manufacturers 3.1 Global Haemophilus Influenzae Type B Vaccine Sales by Manufacturers 3.1.1 Global Top Haemophilus Influenzae Type B Vaccine Manufacturers by Sales (2016-2021) 3.1.2 Global Top Haemophilus Influenzae Type B Vaccine Manufacturers Market Share by Sales (2016-2021) 3.1.3 Global Top 10 and Top 5 Companies by Haemophilus Influenzae Type B Vaccine Sales in 2020 3.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Manufacturers 3.2.1 Global Top Haemophilus Influenzae Type B Vaccine Manufacturers by Revenue (2016-2021) 3.2.2 Global Top Haemophilus Influenzae Type B Vaccine Manufacturers Market Share by Revenue (2016-2021) 3.2.3 Global Top 10 and Top 5 Companies by Haemophilus Influenzae Type B Vaccine Revenue in 2020 3.3 Global Haemophilus Influenzae Type B Vaccine Sales Price by Manufacturers 3.4 Analysis of Competitive Landscape 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Haemophilus Influenzae Type B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.4.3 Global Haemophilus Influenzae Type B Vaccine Manufacturers Geographical Distribution 3.5 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type 4.1 Global Haemophilus Influenzae Type B Vaccine Sales by Type 4.1.1 Global Haemophilus Influenzae Type B Vaccine Historical Sales by Type (2016-2021) 4.1.2 Global Haemophilus Influenzae Type B Vaccine Forecasted Sales by Type (2022-2027) 4.1.3 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2016-2027) 4.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Type 4.2.1 Global Haemophilus Influenzae Type B Vaccine Historical Revenue by Type (2016-2021) 4.2.2 Global Haemophilus Influenzae Type B Vaccine Forecasted Revenue by Type (2022-2027) 4.2.3 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2016-2027) 4.3 Global Haemophilus Influenzae Type B Vaccine Price by Type 4.3.1 Global Haemophilus Influenzae Type B Vaccine Price by Type (2016-2021) 4.3.2 Global Haemophilus Influenzae Type B Vaccine Price Forecast by Type (2022-2027) 5 Market Size by Application 5.1 Global Haemophilus Influenzae Type B Vaccine Sales by Application 5.1.1 Global Haemophilus Influenzae Type B Vaccine Historical Sales by Application (2016-2021) 5.1.2 Global Haemophilus Influenzae Type B Vaccine Forecasted Sales by Application (2022-2027) 5.1.3 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2016-2027) 5.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Application 5.2.1 Global Haemophilus Influenzae Type B Vaccine Historical Revenue by Application (2016-2021) 5.2.2 Global Haemophilus Influenzae Type B Vaccine Forecasted Revenue by Application (2022-2027) 5.2.3 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2016-2027) 5.3 Global Haemophilus Influenzae Type B Vaccine Price by Application 5.3.1 Global Haemophilus Influenzae Type B Vaccine Price by Application (2016-2021) 5.3.2 Global Haemophilus Influenzae Type B Vaccine Price Forecast by Application (2022-2027) 6 North America 6.1 North America Haemophilus Influenzae Type B Vaccine Market Size by Type 6.1.1 North America Haemophilus Influenzae Type B Vaccine Sales by Type (2016-2027) 6.1.2 North America Haemophilus Influenzae Type B Vaccine Revenue by Type (2016-2027) 6.2 North America Haemophilus Influenzae Type B Vaccine Market Size by Application 6.2.1 North America Haemophilus Influenzae Type B Vaccine Sales by Application (2016-2027) 6.2.2 North America Haemophilus Influenzae Type B Vaccine Revenue by Application (2016-2027) 6.3 North America Haemophilus Influenzae Type B Vaccine Market Size by Country 6.3.1 North America Haemophilus Influenzae Type B Vaccine Sales by Country (2016-2027) 6.3.2 North America Haemophilus Influenzae Type B Vaccine Revenue by Country (2016-2027) 6.3.3 U.S. 6.3.4 Canada 7 Europe 7.1 Europe Haemophilus Influenzae Type B Vaccine Market Size by Type 7.1.1 Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2017-2027) 7.1.2 Europe Haemophilus Influenzae Type B Vaccine Revenue by Type (2017-2027) 7.2 Europe Haemophilus Influenzae Type B Vaccine Market Size by Application 7.2.1 Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2017-2027) 7.2.2 Europe Haemophilus Influenzae Type B Vaccine Revenue by Application (2017-2027) 7.3 Europe Haemophilus Influenzae Type B Vaccine Market Size by Country 7.3.1 Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2017-2027) 7.3.2 Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2017-2027) 7.3.3 Germany 7.3.4 France 7.3.5 U.K. 7.3.6 Italy 7.3.7 Russia 8 Asia Pacific 8.1 Asia Pacific Haemophilus Influenzae Type B Vaccine Market Size by Type 8.1.1 Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Type (2018-2027) 8.1.2 Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Type (2018-2027) 8.2 Asia Pacific Haemophilus Influenzae Type B Vaccine Market Size by Application 8.2.1 Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Application (2018-2027) 8.2.2 Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Application (2018-2027) 8.3 Asia Pacific Haemophilus Influenzae Type B Vaccine Market Size by Region 8.3.1 Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Region (2018-2027) 8.3.2 Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Region (2018-2027) 8.3.3 China 8.3.4 Japan 8.3.5 South Korea 8.3.6 India 8.3.7 Australia 8.3.8 Taiwan 8.3.9 Indonesia 8.3.10 Thailand 8.3.11 Malaysia 8.3.12 Philippines 9 Latin America 9.1 Latin America Haemophilus Influenzae Type B Vaccine Market Size by Type 9.1.1 Latin America Haemophilus Influenzae Type B Vaccine Sales by Type (2019-2027) 9.1.2 Latin America Haemophilus Influenzae Type B Vaccine Revenue by Type (2019-2027) 9.2 Latin America Haemophilus Influenzae Type B Vaccine Market Size by Application 9.2.1 Latin America Haemophilus Influenzae Type B Vaccine Sales by Application (2019-2027) 9.2.2 Latin America Haemophilus Influenzae Type B Vaccine Revenue by Application (2019-2027) 9.3 Latin America Haemophilus Influenzae Type B Vaccine Market Size by Country 9.3.1 Latin America Haemophilus Influenzae Type B Vaccine Sales by Country (2019-2027) 9.3.2 Latin America Haemophilus Influenzae Type B Vaccine Revenue by Country (2019-2027) 9.3.3 Mexico 9.3.4 Brazil 9.3.5 Argentina 6 Middle East and Africa 6.1 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Size by Type 6.1.1 Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Type (2016-2027) 6.1.2 Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Type (2016-2027) 6.2 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Size by Application 6.2.1 Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Application (2016-2027) 6.2.2 Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Application (2016-2027) 6.3 Middle East and Africa Haemophilus Influenzae Type B Vaccine Market Size by Country 6.3.1 Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2016-2027) 6.3.2 Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Country (2016-2027) 6.3.3 Turkey 6.3.4 Saudi Arabia 6.3.5 U.A.E 11 Company Profiles 11.1 Novartis 11.1.1 Novartis Corporation Information 11.1.2 Novartis Overview 11.1.3 Novartis Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Novartis Haemophilus Influenzae Type B Vaccine Product Description 11.1.5 Novartis Related Developments 11.2 Merck 11.2.1 Merck Corporation Information 11.2.2 Merck Overview 11.2.3 Merck Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2016-2021) 11.2.4 Merck Haemophilus Influenzae Type B Vaccine Product Description 11.2.5 Merck Related Developments 11.3 Sanofi 11.3.1 Sanofi Corporation Information 11.3.2 Sanofi Overview 11.3.3 Sanofi Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2016-2021) 11.3.4 Sanofi Haemophilus Influenzae Type B Vaccine Product Description 11.3.5 Sanofi Related Developments 11.4 GlaxoSmithKline 11.4.1 GlaxoSmithKline Corporation Information 11.4.2 GlaxoSmithKline Overview 11.4.3 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2016-2021) 11.4.4 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product Description 11.4.5 GlaxoSmithKline Related Developments 11.5 Takeda Pharmaceuticals Company 11.5.1 Takeda Pharmaceuticals Company Corporation Information 11.5.2 Takeda Pharmaceuticals Company Overview 11.5.3 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2016-2021) 11.5.4 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product Description 11.5.5 Takeda Pharmaceuticals Company Related Developments 11.6 Walvax Biotechnology 11.6.1 Walvax Biotechnology Corporation Information 11.6.2 Walvax Biotechnology Overview 11.6.3 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2016-2021) 11.6.4 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product Description 11.6.5 Walvax Biotechnology Related Developments 11.7 Lanzhou Institute of Biologica 11.7.1 Lanzhou Institute of Biologica Corporation Information 11.7.2 Lanzhou Institute of Biologica Overview 11.7.3 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2016-2021) 11.7.4 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product Description 11.7.5 Lanzhou Institute of Biologica Related Developments 11.8 Immunize BC 11.8.1 Immunize BC Corporation Information 11.8.2 Immunize BC Overview 11.8.3 Immunize BC Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2016-2021) 11.8.4 Immunize BC Haemophilus Influenzae Type B Vaccine Product Description 11.8.5 Immunize BC Related Developments 11.1 Novartis 11.1.1 Novartis Corporation Information 11.1.2 Novartis Overview 11.1.3 Novartis Haemophilus Influenzae Type B Vaccine Sales, Price, Revenue and Gross Margin (2016-2021) 11.1.4 Novartis Haemophilus Influenzae Type B Vaccine Product Description 11.1.5 Novartis Related Developments 12 Value Chain and Sales Channels Analysis 12.1 Haemophilus Influenzae Type B Vaccine Value Chain Analysis 12.2 Haemophilus Influenzae Type B Vaccine Key Raw Materials 12.2.1 Key Raw Materials 12.2.2 Raw Materials Key Suppliers 12.3 Haemophilus Influenzae Type B Vaccine Production Mode & Process 12.4 Haemophilus Influenzae Type B Vaccine Sales and Marketing 12.4.1 Haemophilus Influenzae Type B Vaccine Sales Channels 12.4.2 Haemophilus Influenzae Type B Vaccine Distributors 12.5 Haemophilus Influenzae Type B Vaccine Customers 13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis 13.1 Haemophilus Influenzae Type B Vaccine Industry Trends 13.2 Haemophilus Influenzae Type B Vaccine Market Drivers 13.3 Haemophilus Influenzae Type B Vaccine Market Challenges 13.4 Haemophilus Influenzae Type B Vaccine Market Restraints 14 Key Findings in The Global Haemophilus Influenzae Type B Vaccine Study 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Author Details 15.3 Disclaimer

List of Tables Table 1. Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million) Table 2. Major Manufacturers of Liquid Monovalent HIB Table 3. Major Manufacturers of Liquid Combination HIB Table 4. Major Manufacturers of Lyophilized Monovalent HIB Table 5. Major Manufacturers of Lyophilized Combination HIB Table 6. Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million) Table 7. Global Haemophilus Influenzae Type B Vaccine Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million) Table 8. Global Haemophilus Influenzae Type B Vaccine Sales by Region (2016-2021) & (M Doses) Table 9. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2016-2021) Table 10. Global Haemophilus Influenzae Type B Vaccine Sales by Region (2016-2021) & (M Doses) Table 11. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2022-2027) Table 12. Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2016-2021) & (US$ Million) Table 13. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2016-2021) Table 14. Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2022-2027) & (US$ Million) Table 15. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2022-2027) Table 16. Global Haemophilus Influenzae Type B Vaccine Sales by Manufacturers (2016-2021) & (M Doses) Table 17. Global Haemophilus Influenzae Type B Vaccine Sales Share by Manufacturers (2016-2021) Table 18. Global Haemophilus Influenzae Type B Vaccine Revenue by Manufacturers (2016-2021) & (US$ Million) Table 19. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Manufacturers (2016-2021) Table 20. Haemophilus Influenzae Type B Vaccine Price by Manufacturers 2016-2021 (USD/Dose) Table 21. Global Haemophilus Influenzae Type B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI) Table 22. Global Haemophilus Influenzae Type B Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Haemophilus Influenzae Type B Vaccine as of 2020) Table 23. Haemophilus Influenzae Type B Vaccine Manufacturing Base Distribution and Headquarters Table 24. Manufacturers Haemophilus Influenzae Type B Vaccine Product Offered Table 25. Date of Manufacturers Enter into Haemophilus Influenzae Type B Vaccine Market Table 26. Mergers & Acquisitions, Expansion Plans Table 27. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2016-2021) & (M Doses) Table 28. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2022-2027) & (M Doses) Table 29. Global Haemophilus Influenzae Type B Vaccine Sales Share by Type (2016-2021) Table 30. Global Haemophilus Influenzae Type B Vaccine Sales Share by Type (2022-2027) Table 31. Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2016-2021) & (US$ Million) Table 32. Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2022-2027) & (US$ Million) Table 33. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Type (2016-2021) Table 34. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Type (2022-2027) Table 35. Haemophilus Influenzae Type B Vaccine Price by Type (2016-2021) & (USD/Dose) Table 36. Global Haemophilus Influenzae Type B Vaccine Price Forecast by Type (2022-2027) & (USD/Dose) Table 37. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2016-2021) & (M Doses) Table 38. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2022-2027) & (M Doses) Table 39. Global Haemophilus Influenzae Type B Vaccine Sales Share by Application (2016-2021) Table 40. Global Haemophilus Influenzae Type B Vaccine Sales Share by Application (2022-2027) Table 41. Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2016-2021) & (US$ Million) Table 42. Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2022-2027) & (US$ Million) Table 43. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Application (2016-2021) Table 44. Global Haemophilus Influenzae Type B Vaccine Revenue Share by Application (2022-2027) Table 45. Haemophilus Influenzae Type B Vaccine Price by Application (2016-2021) & (USD/Dose) Table 46. Global Haemophilus Influenzae Type B Vaccine Price Forecast by Application (2022-2027) & (USD/Dose) Table 47. North America Haemophilus Influenzae Type B Vaccine Sales by Type (2016-2021) & (M Doses) Table 48. North America Haemophilus Influenzae Type B Vaccine Sales by Type (2022-2027) & (M Doses) Table 49. North America Haemophilus Influenzae Type B Vaccine Revenue by Type (2016-2021) & (US$ Million) Table 50. North America Haemophilus Influenzae Type B Vaccine Revenue by Type (2022-2027) & (US$ Million) Table 51. North America Haemophilus Influenzae Type B Vaccine Sales by Application (2016-2021) & (M Doses) Table 52. North America Haemophilus Influenzae Type B Vaccine Sales by Application (2022-2027) & (M Doses) Table 53. North America Haemophilus Influenzae Type B Vaccine Revenue by Application (2016-2021) & (US$ Million) Table 54. North America Haemophilus Influenzae Type B Vaccine Revenue by Application (2022-2027) & (US$ Million) Table 55. North America Haemophilus Influenzae Type B Vaccine Sales by Country (2016-2021) & (M Doses) Table 56. North America Haemophilus Influenzae Type B Vaccine Sales by Country (2022-2027) & (M Doses) Table 57. North America Haemophilus Influenzae Type B Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 58. North America Haemophilus Influenzae Type B Vaccine Revenue by Country (2022-2027) & (US$ Million) Table 59. Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2016-2021) & (M Doses) Table 60. Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2022-2027) & (M Doses) Table 61. Europe Haemophilus Influenzae Type B Vaccine Revenue by Type (2016-2021) & (US$ Million) Table 62. Europe Haemophilus Influenzae Type B Vaccine Revenue by Type (2022-2027) & (US$ Million) Table 63. Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2016-2021) & (M Doses) Table 64. Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2022-2027) & (M Doses) Table 65. Europe Haemophilus Influenzae Type B Vaccine Revenue by Application (2016-2021) & (US$ Million) Table 66. Europe Haemophilus Influenzae Type B Vaccine Revenue by Application (2022-2027) & (US$ Million) Table 67. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2016-2021) & (M Doses) Table 68. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2022-2027) & (M Doses) Table 69. Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 70. Europe Haemophilus Influenzae Type B Vaccine Revenue by Country (2022-2027) & (US$ Million) Table 71. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Type (2016-2021) & (M Doses) Table 72. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Type (2022-2027) & (M Doses) Table 73. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Type (2016-2021) & (US$ Million) Table 74. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Type (2022-2027) & (US$ Million) Table 75. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Application (2016-2021) & (M Doses) Table 76. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Application (2022-2027) & (M Doses) Table 77. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Application (2016-2021) & (US$ Million) Table 78. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Application (2022-2027) & (US$ Million) Table 79. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Region (2016-2021) & (M Doses) Table 80. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales by Region (2022-2027) & (M Doses) Table 81. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Region (2016-2021) & (US$ Million) Table 82. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue by Region (2022-2027) & (US$ Million) Table 83. Latin America Haemophilus Influenzae Type B Vaccine Sales by Type (2016-2021) & (M Doses) Table 84. Latin America Haemophilus Influenzae Type B Vaccine Sales by Type (2022-2027) & (M Doses) Table 85. Latin America Haemophilus Influenzae Type B Vaccine Revenue by Type (2016-2021) & (US$ Million) Table 86. Latin America Haemophilus Influenzae Type B Vaccine Revenue by Type (2022-2027) & (US$ Million) Table 87. Latin America Haemophilus Influenzae Type B Vaccine Sales by Application (2016-2021) & (M Doses) Table 88. Latin America Haemophilus Influenzae Type B Vaccine Sales by Application (2022-2027) & (M Doses) Table 89. Latin America Haemophilus Influenzae Type B Vaccine Revenue by Application (2016-2021) & (US$ Million) Table 90. Latin America Haemophilus Influenzae Type B Vaccine Revenue by Application (2022-2027) & (US$ Million) Table 91. Latin America Haemophilus Influenzae Type B Vaccine Sales by Country (2016-2021) & (M Doses) Table 92. Latin America Haemophilus Influenzae Type B Vaccine Sales by Country (2022-2027) & (M Doses) Table 93. Latin America Haemophilus Influenzae Type B Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 94. Latin America Haemophilus Influenzae Type B Vaccine Revenue by Country (2022-2027) & (US$ Million) Table 95. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Type (2016-2021) & (M Doses) Table 96. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Type (2022-2027) & (M Doses) Table 97. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Type (2016-2021) & (US$ Million) Table 98. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Type (2022-2027) & (US$ Million) Table 99. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Application (2016-2021) & (M Doses) Table 100. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Application (2022-2027) & (M Doses) Table 101. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Application (2016-2021) & (US$ Million) Table 102. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Application (2022-2027) & (US$ Million) Table 103. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2016-2021) & (M Doses) Table 104. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales by Country (2022-2027) & (M Doses) Table 105. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Country (2016-2021) & (US$ Million) Table 106. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue by Country (2022-2027) & (US$ Million) Table 107. Novartis Corporation Information Table 108. Novartis Description and Major Businesses Table 109. Novartis Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 110. Novartis Haemophilus Influenzae Type B Vaccine Product Table 111. Novartis Recent Developments Table 112. Merck Corporation Information Table 113. Merck Description and Major Businesses Table 114. Merck Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 115. Merck Haemophilus Influenzae Type B Vaccine Product Table 116. Merck Recent Developments Table 117. Sanofi Corporation Information Table 118. Sanofi Description and Major Businesses Table 119. Sanofi Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 120. Sanofi Haemophilus Influenzae Type B Vaccine Product Table 121. Sanofi Recent Developments Table 122. GlaxoSmithKline Corporation Information Table 123. GlaxoSmithKline Description and Major Businesses Table 124. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 125. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product Table 126. GlaxoSmithKline Recent Developments Table 127. Takeda Pharmaceuticals Company Corporation Information Table 128. Takeda Pharmaceuticals Company Description and Major Businesses Table 129. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 130. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product Table 131. Takeda Pharmaceuticals Company Recent Developments Table 132. Walvax Biotechnology Corporation Information Table 133. Walvax Biotechnology Description and Major Businesses Table 134. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 135. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product Table 136. Walvax Biotechnology Recent Developments Table 137. Lanzhou Institute of Biologica Corporation Information Table 138. Lanzhou Institute of Biologica Description and Major Businesses Table 139. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 140. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product Table 141. Lanzhou Institute of Biologica Recent Developments Table 142. Immunize BC Corporation Information Table 143. Immunize BC Description and Major Businesses Table 144. Immunize BC Haemophilus Influenzae Type B Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2016-2021) Table 145. Immunize BC Haemophilus Influenzae Type B Vaccine Product Table 146. Immunize BC Recent Developments Table 147. Key Raw Materials Lists Table 148. Raw Materials Key Suppliers Lists Table 149. Haemophilus Influenzae Type B Vaccine Distributors List Table 150. Haemophilus Influenzae Type B Vaccine Customers List Table 151. Haemophilus Influenzae Type B Vaccine Market Trends Table 152. Haemophilus Influenzae Type B Vaccine Market Drivers Table 153. Haemophilus Influenzae Type B Vaccine Market Challenges Table 154. Haemophilus Influenzae Type B Vaccine Market Restraints Table 155. Research Programs/Design for This Report Table 156. Key Data Information from Secondary Sources Table 157. Key Data Information from Primary Sources List of Figures Figure 1. Haemophilus Influenzae Type B Vaccine Product Picture Figure 2. Global Haemophilus Influenzae Type B Vaccine Market Share by Type in 2020 & 2027 Figure 3. Liquid Monovalent HIB Product Picture Figure 4. Liquid Combination HIB Product Picture Figure 5. Lyophilized Monovalent HIB Product Picture Figure 6. Lyophilized Combination HIB Product Picture Figure 7. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application in 2020 & 2027 Figure 8. Hospital Figure 9. Research Institutions Figure 10. Pharmaceutical and Biotechnology Companies Figure 11. Academic Institutions Figure 12. Other Figure 13. Haemophilus Influenzae Type B Vaccine Report Years Considered Figure 14. Global Haemophilus Influenzae Type B Vaccine Sales 2016-2027 (M Doses) Figure 15. Global Haemophilus Influenzae Type B Vaccine Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 16. Global Haemophilus Influenzae Type B Vaccine Revenue 2016-2027 (US$ Million) Figure 17. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region in Percentage: 2020 Versus 2027 Figure 18. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2016-2021) Figure 19. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2022-2027) Figure 20. North America Haemophilus Influenzae Type B Vaccine Sales YoY (2016-2027) & (M Doses) Figure 21. North America Haemophilus Influenzae Type B Vaccine Revenue YoY (2016-2027) & (US$ Million) Figure 22. Europe Haemophilus Influenzae Type B Vaccine Sales YoY (2016-2027) & (M Doses) Figure 23. Europe Haemophilus Influenzae Type B Vaccine Revenue YoY (2016-2027) & (US$ Million) Figure 24. Asia-Pacific Haemophilus Influenzae Type B Vaccine Sales YoY (2016-2027) & (M Doses) Figure 25. Asia-Pacific Haemophilus Influenzae Type B Vaccine Revenue YoY (2016-2027) & (US$ Million) Figure 26. Latin America Haemophilus Influenzae Type B Vaccine Sales YoY (2016-2027) & (M Doses) Figure 27. Latin America Haemophilus Influenzae Type B Vaccine Revenue YoY (2016-2027) & (US$ Million) Figure 28. Middle East & Africa Haemophilus Influenzae Type B Vaccine Sales YoY (2016-2027) & (M Doses) Figure 29. Middle East & Africa Haemophilus Influenzae Type B Vaccine Revenue YoY (2016-2027) & (US$ Million) Figure 30. The Top 10 and Top 5 Players Market Share by Haemophilus Influenzae Type B Vaccine Sales in 2020 Figure 31. The Top 10 and Top 5 Players Market Share by Haemophilus Influenzae Type B Vaccine Revenue in 2020 Figure 32. Haemophilus Influenzae Type B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020 Figure 33. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2016-2027) Figure 34. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2016-2027) Figure 35. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2016-2027) Figure 36. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2016-2027) Figure 37. North America Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2016-2027) Figure 38. North America Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2016-2027) Figure 39. North America Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2016-2027) Figure 40. North America Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2016-2027) Figure 41. North America Haemophilus Influenzae Type B Vaccine Sales Share by Country (2016-2027) Figure 42. North America Haemophilus Influenzae Type B Vaccine Revenue Share by Country (2016-2027) Figure 43. U.S. Haemophilus Influenzae Type B Vaccine Revenue (2016-2027) & (US$ Million) Figure 44. Canada Haemophilus Influenzae Type B Vaccine Revenue (2016-2027) & (US$ Million) Figure 45. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2016-2027) Figure 46. Europe Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2016-2027) Figure 47. Europe Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2016-2027) Figure 48. Europe Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2016-2027) Figure 49. Europe Haemophilus Influenzae Type B Vaccine Sales Share by Country (2016-2027) Figure 50. Europe Haemophilus Influenzae Type B Vaccine Revenue Share by Country (2016-2027) Figure 51. Germany Haemophilus Influenzae Type B Vaccine Revenue (2016-2027) & (US$ Million) Figure 52. France Haemophilus Influenzae Type B Vaccine Revenue (2016-2027) & (US$ Million) Figure 53. U.K. Haemophilus Influenzae Type B Vaccine Revenue (2016-2027) & (US$ Million) Figure 54. Italy Haemophilus Influenzae Type B Vaccine Revenue (2016-2027) & (US$ Million) Figure 55. Russia Haemophilus Influenzae Type B Vaccine Revenue (2016-2027) & (US$ Million) Figure 56. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2016-2027) Figure 57. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2016-2027) Figure 58. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2016-2027) Figure 59. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2016-2027) Figure 60. Asia Pacific Haemophilus Influenzae Type B Vaccine Sales Share by Region (2016-2027) Figure 61. Asia Pacific Haemophilus Influenzae Type B Vaccine Revenue Share by Region (2016-2027) Figure 62. China Haemophilus Influenzae Type B Vaccine Revenue (2016-2027) & (US$ Million) Figure 63. Japan Haemophilus Influenzae Type B Vaccine Revenue (2016-2027) & (US$ Million) Figure 64. South Korea Haemophilus Influenzae Type B Vaccine Revenue (2016-2027) & (US$ Million) Figure 65. India Haemophilus Influenzae Type B Vaccine Revenue (2016-2027) & (US$ Million) Figure 66. Australia Haemophilus Influenzae Type B Vaccine Revenue (2016-2027) & (US$ Million) Figure 67. Taiwan Haemophilus Influenzae Type B Vaccine Revenue (2016-2027) & (US$ Million) Figure 68. Indonesia Haemophilus Influenzae Type B Vaccine Revenue (2016-2027) & (US$ Million) Figure 69. Thailand Haemophilus Influenzae Type B Vaccine Revenue (2016-2027) & (US$ Million) Figure 70. Malaysia Haemophilus Influenzae Type B Vaccine Revenue (2016-2027) & (US$ Million) Figure 71. Philippines Haemophilus Influenzae Type B Vaccine Revenue (2016-2027) & (US$ Million) Figure 72. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2016-2027) Figure 73. Latin America Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2016-2027) Figure 74. Latin America Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2016-2027) Figure 75. Latin America Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2016-2027) Figure 76. Latin America Haemophilus Influenzae Type B Vaccine Sales Share by Country (2016-2027) Figure 77. Latin America Haemophilus Influenzae Type B Vaccine Revenue Share by Country (2016-2027) Figure 78. Mexico Haemophilus Influenzae Type B Vaccine Revenue (2016-2027) & (US$ Million) Figure 79. Brazil Haemophilus Influenzae Type B Vaccine Revenue (2016-2027) & (US$ Million) Figure 80. Argentina Haemophilus Influenzae Type B Vaccine Revenue (2016-2027) & (US$ Million) Figure 81. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2016-2027) Figure 82. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2016-2027) Figure 83. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2016-2027) Figure 84. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2016-2027) Figure 85. Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales Share by Country (2016-2027) Figure 86. Middle East and Africa Haemophilus Influenzae Type B Vaccine Revenue Share by Country (2016-2027) Figure 87. Turkey Haemophilus Influenzae Type B Vaccine Revenue (2016-2027) & (US$ Million) Figure 88. Saudi Arabia Haemophilus Influenzae Type B Vaccine Revenue (2016-2027) & (US$ Million) Figure 89. U.A.E Haemophilus Influenzae Type B Vaccine Revenue (2016-2027) & (US$ Million) Figure 90. Haemophilus Influenzae Type B Vaccine Value Chain Figure 91. Haemophilus Influenzae Type B Vaccine Production Process Figure 92. Channels of Distribution Figure 93. Distributors Profiles Figure 94. Bottom-up and Top-down Approaches for This Report Figure 95. Data Triangulation Figure 96. Key Executives Interviewed

Novartis Merck Sanofi GlaxoSmithKline Takeda Pharmaceuticals Company Walvax Biotechnology Lanzhou Institute of Biologica Immunize BC